215 related articles for article (PubMed ID: 34062254)
1. Interrelationship between the 5-lipoxygenase pathway and microbial dysbiosis in the progression of Alzheimer's disease.
Mathis SP; Bodduluri SR; Haribabu B
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Sep; 1866(9):158982. PubMed ID: 34062254
[TBL] [Abstract][Full Text] [Related]
2. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C
Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
Nagu P; Parashar A; Behl T; Mehta V
J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota regulate Alzheimer's disease pathologies and cognitive disorders via PUFA-associated neuroinflammation.
Chen C; Liao J; Xia Y; Liu X; Jones R; Haran J; McCormick B; Sampson TR; Alam A; Ye K
Gut; 2022 Nov; 71(11):2233-2252. PubMed ID: 35017199
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment.
Liu S; Gao J; Zhu M; Liu K; Zhang HL
Mol Neurobiol; 2020 Dec; 57(12):5026-5043. PubMed ID: 32829453
[TBL] [Abstract][Full Text] [Related]
6. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer's disease animal model.
Kim MS; Kim Y; Choi H; Kim W; Park S; Lee D; Kim DK; Kim HJ; Choi H; Hyun DW; Lee JY; Choi EY; Lee DS; Bae JW; Mook-Jung I
Gut; 2020 Feb; 69(2):283-294. PubMed ID: 31471351
[TBL] [Abstract][Full Text] [Related]
7. Intestinal microbial dysbiosis aggravates the progression of Alzheimer's disease in Drosophila.
Wu SC; Cao ZS; Chang KM; Juang JL
Nat Commun; 2017 Jun; 8(1):24. PubMed ID: 28634323
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.
Shabbir U; Arshad MS; Sameen A; Oh DH
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988
[TBL] [Abstract][Full Text] [Related]
9. Injection of amyloid-β to lateral ventricle induces gut microbiota dysbiosis in association with inhibition of cholinergic anti-inflammatory pathways in Alzheimer's disease.
Qian XH; Liu XL; Chen G; Chen SD; Tang HD
J Neuroinflammation; 2022 Sep; 19(1):236. PubMed ID: 36171620
[TBL] [Abstract][Full Text] [Related]
10. The 5-Lipoxygenase as modulator of Alzheimer's γ-secretase and therapeutic target.
Chu J; Praticò D
Brain Res Bull; 2016 Sep; 126(Pt 2):207-212. PubMed ID: 27005438
[TBL] [Abstract][Full Text] [Related]
11. Time to test antibacterial therapy in Alzheimer's disease.
Panza F; Lozupone M; Solfrizzi V; Watling M; Imbimbo BP
Brain; 2019 Oct; 142(10):2905-2929. PubMed ID: 31532495
[TBL] [Abstract][Full Text] [Related]
12. Interlink between the gut microbiota and inflammation in the context of oxidative stress in Alzheimer's disease progression.
Das TK; Ganesh BP
Gut Microbes; 2023; 15(1):2206504. PubMed ID: 37127846
[TBL] [Abstract][Full Text] [Related]
13. Dysbiosis and Alzheimer's Disease: A Role for Chronic Stress?
Sharma VK; Singh TG; Garg N; Dhiman S; Gupta S; Rahman MH; Najda A; Walasek-Janusz M; Kamel M; Albadrani GM; Akhtar MF; Saleem A; Altyar AE; Abdel-Daim MM
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33946488
[TBL] [Abstract][Full Text] [Related]
14. The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer's Disease-a Critical Review.
Sochocka M; Donskow-Łysoniewska K; Diniz BS; Kurpas D; Brzozowska E; Leszek J
Mol Neurobiol; 2019 Mar; 56(3):1841-1851. PubMed ID: 29936690
[TBL] [Abstract][Full Text] [Related]
15. The Gut Microbiota and Alzheimer's Disease.
Jiang C; Li G; Huang P; Liu Z; Zhao B
J Alzheimers Dis; 2017; 58(1):1-15. PubMed ID: 28372330
[TBL] [Abstract][Full Text] [Related]
16. Dysbiosis and Alzheimer's Disease: Cause or Treatment Opportunity?
Janeiro MH; Ramírez MJ; Solas M
Cell Mol Neurobiol; 2022 Mar; 42(2):377-387. PubMed ID: 33400081
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway.
Haran JP; Bhattarai SK; Foley SE; Dutta P; Ward DV; Bucci V; McCormick BA
mBio; 2019 May; 10(3):. PubMed ID: 31064831
[TBL] [Abstract][Full Text] [Related]
18. Gut Microbiota, Its Role in Induction of Alzheimer's Disease Pathology, and Possible Therapeutic Interventions: Special Focus on Anthocyanins.
Khan MS; Ikram M; Park JS; Park TJ; Kim MO
Cells; 2020 Apr; 9(4):. PubMed ID: 32244729
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota and Alzheimer's Disease: Pathophysiology and Therapeutic Perspectives.
Li Y; Wang R; Li Q; Wang YJ; Guo J
J Alzheimers Dis; 2021; 83(3):963-976. PubMed ID: 34366348
[TBL] [Abstract][Full Text] [Related]
20. Knockout of 5-lipoxygenase prevents dexamethasone-induced tau pathology in 3xTg mice.
Joshi YB; Chu J; Praticò D
Aging Cell; 2013 Aug; 12(4):706-11. PubMed ID: 23634895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
